Clinical Trials · NCT00626431

A Study of Leuprolide to Treat Prostate Cancer

Name: A Study of Leuprolide to Treat Prostate Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Gonadorelin

Phase: Phase 3
Recruitment status: Completed
Sponsor: Abbott
Enrollment: 310
Start date: Feb 2008
Locations: 63 sites, United States
Primary endpoint: Percentage of Subjects With Suppression of Serum Testosterone (<=50 ng/dL) From Week 4 to Week 48 for Formulation A: Intent-to-treat (ITT) Population for the Primary Endpoint.

View Gonadorelin compound reference